Bringing the fundamentals into focus…
Back to Ascentage Pharma Group Internat
How Ascentage Pharma Group Internat stacks up
AAPG · against 447 other Healthcare companies of similar size
Profitability
9/ 100
Near the bottom of its peers.
Ranked #413 of 448 · scores higher than 7% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 0–9, including AAPG · Click a bar to see the companies
Why profitability scores 9?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 98% of peers. Return on invested capital: -447.5% vs peer median 4.7%
- a thinner operating margin: weaker than 90% of peers. Operating margin: -208.6% vs peer median 7.1%
- a lower return on assets: weaker than 85% of peers. Return on assets: -28.0% vs peer median 1.7%
Metric by metric
Position: dot = AAPG, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AAPG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 424 reported | -447.5% | 5.1% | 1% | 33% | |
| Operating marginHigher is better · 419 reported | -208.6% | 6.9% | 8% | 33% | |
| Return on assetsHigher is better · 436 reported | -28.0% | 1.8% | 14% | 33% | |
| Return on equityHigher is better · 419 reported | -236.6% | 3.1% | 3% | Context only | |
| Gross marginHigher is better · 468 reported | 93.9% | 47.0% | 96% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around AAPG| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 914M USD | 99 | 81 | |
| 408 | 2.2B USD | 11 | 48 | |
| 408 | 1.2B USD | 11 | 40 | |
| 408 | 976M USD | 11 | 36 | |
| 413 | 9.9B HKD (≈$1.3B) | 9 | 17 | |
| 413 | 1.3B USD | 9 | 15 | |
| 413 | 996M USD | 9 | 35 | |
| 413 | 730M USD | 9 | 11 | |
| 417 | 2.4B USD | 8 | 6 | |
| 417 | 1.9B USD | 8 | 18 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score